Prevention and Early Treatment of PPH: A Call To Action For Addressing Barriers And Inequities
Jan. 31, 2022 8:30am - 3pm
Course Directors:
Homa Ahmadzia, MD, MPH
Elizabeth Stringer, MD
Course Faculty:
Ahizechukwu Eke, MD, PhD
Catherine Eppes, MD
Jerome Federspiel, MD, PhD
Ioannis Gallos, MD
Wanda Irving, MPA
Charles Johnson,
Megan Lord, MD
Elliott Main, MD
Luis Pacheco, MD
Jaclyn Phillips, MD
Ian Roberts, MD, PhD
Sara Sakamoto, MD
Course Description:
Pregnancy related bleeding and clotting issues account for a third of maternal deaths worldwide. Despite the impact of postpartum hemorrhage there has been a disproportionately limited amount of research addressing the problem. This course will provide updates on specific gaps in research regarding the prediction, prevention and treatment of postpartum hemorrhage while providing information on where we currently are in addressing PPH through implementation science, prediction optimization, timely existing medical treatments, and upcoming clinical trials. This course will also address racial and systemic inequities that account for the overwhelming discrepancy in maternal mortality among different racial and ethnic groups in the United States. The goal of the course is to serve as both a call to action to inspire innovation as well as outline priorities for obstetric providers to reduce maternal mortality and morbidity globally.
Learning Objectives: ·
Course Schedule (All times Eastern Standard Time):
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Learning Collaborative (GLC) and SMFM. GLC is accredited by the ACCME to provide continuing medical education for physicians.
Global Learning Collaborative designates this enduring material for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pregnancy related bleeding and clotting issues account for a third of maternal deaths worldwide. Despite the impact of postpartum hemorrhage there has been a disproportionately limited amount of research addressing the problem. This course will provide updates on specific gaps in research regarding the prediction, prevention and treatment of postpartum hemorrhage while providing information on where we currently are in addressing PPH through implementation science, prediction optimization, timely existing medical treatments, and upcoming clinical trials. This course will also address racial and systemic inequities that account for the overwhelming discrepancy in maternal mortality among different racial and ethnic groups in the United States. The goal of the course is to serve as both a call to action to inspire innovation as well as outline priorities for obstetric providers to reduce maternal mortality and morbidity globally.
Learning Objectives: ·
- To identify barriers and solutions to prevention of PPH and timely management with efficacious therapeutics(i.e. tranexamic acid).
- Create ‘benchmarks’ for clinical audits as facilities monitor timely PPH management (i.e. use of TXA within one hour of diagnosed PPH).
- Review successful implementation science strategies that can be utilized to mitigate inequities among women of color and those in low resource settings
- Highlight ongoing discovery/translational research and future pipeline of biomarkers/devices to advance early detection and management of PPH.
Course Schedule (All times Eastern Standard Time):
| 8:30 AM | 8:35 AM | Intro Remarks | Ahmadzia, Stringer |
| 8:35 AM | 8:55 AM | Recognizing who is at risk: targeting anemic women and scoring systems for clinical use | Ahmadzia |
| 8:55 AM | 9:15 AM | Treat early: PPH evidence based single and combined pharmacologic interventions | Eke |
| 9:15 AM | 9:35 AM | To identify barriers and solutions to early PPH management with efficacious therapeutics | Eppes |
| 9:35 AM | 10:00 AM | Panel Discussion | Ahmadzia, Eke, Eppes |
| 10:30 AM | 10:50 AM | Impact of CMQCC bundles on reducing inequities of care | Main |
| 10:50 AM | 11:10 AM | Create 'benchmarks' for clinical audits as facilities monitor timely PPH management | Federspiel |
| 11:10 AM | 11:30 AM | Evidence behind bundles of care in LMIC | Gallos |
| 11:30 AM | 12:00 PM | Panel Discussion | Federspiel, Gallos, Main |
| 1:00 PM | 1:25 PM | Keynote Presentation | Irving, Johnson |
| 1:25 PM | 1:45 PM | Alternative TXA formulations improving accessibility for all | Roberts |
| 1:45 PM | 2:05 PM | New devices and biomarkers in PPH for early detection | Lord, Pacheco |
| 2:05 PM | 2:35 PM | Uterine tamponade devices and suction devices: current evidence | Burke, Phillips, Sakamoto, Rodriguez |
| 2:35 PM | 3:00 PM | Panel discussion and Networking Opportunity | Roberts, Lord, Phillips, Sakamoto, Rodriguez |
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Learning Collaborative (GLC) and SMFM. GLC is accredited by the ACCME to provide continuing medical education for physicians.
Global Learning Collaborative designates this enduring material for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Price: $685.00